Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 27,078	$ 49,229
Prepaid expenses and other current assets	2,161	7,409
Total current assets	29,239	56,638
Property and equipment, net	704	855
Operating right-of-use asset, net	171
Restricted cash	100	100
Deferred offering costs	332	332
Total assets	30,546	57,925
Current liabilities:
Accounts payable	3,139	3,077
Accrued expenses and other current liabilities	4,230	6,651
Total current liabilities	7,369	9,728
Other long-term liabilities	93	12
Total liabilities	7,462	9,740
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021, respectively
Common stock, $0.0001 par value; 200,000,000 shares authorized; 12,127,594 and 12,110,373 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	1	1
Additional paid-in capital	131,298	127,289
Accumulated deficit	(108,215)	(79,105)
Total stockholders' equity	23,084	48,185
Total liabilities and stockholders' equity	$ 30,546	$ 57,925